SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-028311
Filing Date
2023-06-15
Accepted
2023-06-15 16:31:00
Documents
4
Period of Report
2023-07-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A snse-proxy-2023_non-xbrl.htm DEF 14A 1319842
2 GRAPHIC img112193509_0.jpg GRAPHIC 33415
3 GRAPHIC img112193509_1.jpg GRAPHIC 1397024
4 GRAPHIC img112193509_2.jpg GRAPHIC 783608
  Complete submission text file 0000950170-23-028311.txt   4369483
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39980 | Film No.: 231017822
SIC: 2834 Pharmaceutical Preparations